T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita

Journal of Immunology

Volumn 184, Issue 3, 2010, Pages 1596-1603

  Sitaru, Ana Gabriela ^a   Sesarman, Alina ^a   Mihai, Sidonia ^a   Chiriac, Mircea T ^a   Zillikens, Detlef ^a   Hultman, Per ^c   Solbach, Werner ^a   Sitaru, Cassian ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; B LYMPHOCYTE ANTIGEN; COLLAGEN TYPE 7; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; T LYMPHOCYTE ANTIGEN; EPITOPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; BLISTER; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA ACQUISITA; FLOW CYTOMETRY; IN VITRO STUDY; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN BIOPSY; T LYMPHOCYTE; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE STRAIN; NUDE MOUSE; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; BLISTER; CELLS, CULTURED; COLLAGEN TYPE VII; DISEASE MODELS, ANIMAL; EPIDERMOLYSIS BULLOSA ACQUISITA; EPITOPES, T-LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MICE, NUDE; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTE SUBSETS;

EID: 77949327289     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901412     Document Type: Article

References (43)

1. Mihai, S., and C. Sitaru. 2007. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J. Cell. Mol. Med. 11: 462-481.
2. Sitaru, C. 2007. Experimental models of epidermolysis bullosa acquisita. Exp. Dermatol. 16: 520-531.
3. Sitaru, C., A. Kromminga, T. Hashimoto, E. B. Bröcker, and D. Zillikens. 2002. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am. J. Pathol. 161: 301-311.
4. Sitaru, C., S. Mihai, C. Otto, M. T. Chiriac, I. Hausser, B. Dotterweich, H. Saito, C. Rose, A. Ishiko, and D. Zillikens. 2005. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J. Clin. Invest. 115: 870-878.
5. Sitaru, C., M. T. Chiriac, S. Mihai, J. Büning, A. Gebert, A. Ishiko, and D. Zillikens. 2006. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J. Immunol. 177: 3461-3468. (Pubitemid 44277867)
6. Müller, R., C. Dahler, E. Mobs, E. Wenzel, G. Veldman, G. Messer, S. Hofmann, M. Hertl, and A. Niedermeier. 2007. T and B cell responses targeting distinct regions of the non-collagenous domain (NC) 1 domain of type VII collagen correlate with the clinical activity of EBA. J. Invest. Dermatol. 127: S67 (Abstr.).
7. Chiriac, M. T., J. Roesler, A. Sindrilaru, K. Scharffetter-Kochanek, D. Zillikens, and C. Sitaru. 2007. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J. Pathol. 212: 56-65.
8. Sitaru, C., and D. Zillikens. 2005. Mechanisms of blister induction by autoantibodies. Exp. Dermatol. 14: 861-875.
9. Connolly, K., J. R. Roubinian, and D. Wofsy. 1992. Development of murine lupus in CD4-depleted NZB/NZW mice. Sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity. J. Immunol. 149: 3083-3088.
10. Waldor, M. K., S. Sriram, H. O. McDevitt, and L. Steinman. 1983. In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor. Proc. Natl. Acad. Sci. USA 80: 2713-2717.
11. Zhang, G. X., B. G. Xiao, M. Bakhiet, P. van der Meide, H. Wigzell, H. Link, and T. Olsson. 1996. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis. J. Exp. Med. 184: 349-356.
12. Kalluri, R., T. M. Danoff, H. Okada, and E. G. Neilson. 1997. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J. Clin. Invest. 100: 2263-2275.
13. Fischer, K., H. Collins, M. Taniguchi, S. H. E. Kaufmann, and U. E. Schaible. 2002. IL-4 and T cells are required for the generation of IgG1 isotype antibodies against cardiolipin. J. Immunol. 168: 2689-2694. (Pubitemid 34211645)
14. Takahashi, H., M. Amagai, T. Nishikawa, Y. Fujii, Y. Kawakami, and M. Kuwana. 2008. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. J. Immunol. 181: 1526-1535.
15. Tsunoda, K., T. Ota, H. Suzuki, M. Ohyama, T. Nagai, T. Nishikawa, M. Amagai, and S. Koyasu. 2002. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris. Eur. J. Immunol. 32: 627-633.
16. Kaul, R., M. Shenoy, E. Goluszko, and P. Christadoss. 1994. Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis. J. Immunol. 152: 3152-3157. (Pubitemid 24098013)
17. Groom, J., and F. Mackay. 2008. B cells flying solo. Immunol. Cell Biol. 86: 40-46.
18. Mackay, F., J. R. Groom, and S. G. Tangye. 2007. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome. Curr. Opin. Rheumatol. 19: 406-413.
19. Herlands, R. A., S. R. Christensen, R. A. Sweet, U. Hershberg, and M. J. Shlomchik. 2008. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity 29: 249-260.
20. Hultman, P., K. Ganowiak, S. J. Turley, and K. M. Pollard. 1995. Genetic susceptibility to silver-induced anti-fibrillarin autoantibodies in mice. Clin. Immunol. Immunopathol. 77: 291-297.
21. Sesarman, A., A. G. Sitaru, F. Olaru, D. Zillikens, and C. Sitaru. 2008. Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita. J. Mol. Med. 86: 951-959.
22. Sesarman, A., S. Mihai, M. T. Chiriac, F. Olaru, A. G. Sitaru, J. M. Thurman, D. Zillikens, and C. Sitaru. 2008. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice. Br. J. Dermatol. 158: 463-471.
23. Kolaskar, A. S., and P. C. Tongaonkar. 1990. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 276: 172-174.
24. Rice, P., I. Longden, and A. Bleasby. 2000. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16: 276-277.
25. Sitaru, A. G., C. P. Speer, S. Holzhauer, A. Obergfell, U. Walter, and R. Grossmann. 2005. Chorioamnionitis is associated with increased CD40L expression on cord blood platelets. Thromb. Haemost. 94: 1219-1223.
26. Sitaru, A. G., S. Holzhauer, C. P. Speer, D. Singer, A. Obergfell, U. Walter, and R. Grossmann. 2005. Neonatal platelets from cord blood and peripheral blood. Platelets 16: 203-210.
27. Shimanovich, I., S. Mihai, G. J. Oostingh, T. T. Ilenchuk, E. B. Bröcker, G. Opdenakker, D. Zillikens, and C. Sitaru. 2004. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J. Pathol. 204: 519-527.
28. Sitaru, A. G., W. Timmermann, K. Ulrichs, and C. Otto. 2002. Hierarchical immunogenicity of donor MHC class I peptides in allotransplantation. Hum. Immunol. 63: 871-879.
29. Sitaru, A. G., W. Timmermann, K. Ulrichs, and C. Otto. 2004. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition. Hum. Immunol. 65: 817-825.
30. Lapiere, J. C., D. T. Woodley, M. G. Parente, T. Iwasaki, K. C. Wynn, A. M. Christiano, and J. Uitto. 1993. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J. Clin. Invest. 92: 1831-1839.
31. Tanaka, T., F. Furukawa, and S. Imamura. 1994. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J. Invest. Dermatol. 102: 706-709.
32. Woodley, D. T., C. Chang, P. Saadat, R. Ram, Z. Liu, and M. Chen. 2005. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J. Invest. Dermatol. 124: 958-964.
33. Chen, M., A. Doostan, P. Bandyopadhyay, J. Remington, X. Wang, Y. Hou, Z. Liu, and D. T. Woodley. 2007. The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am. J. Pathol. 170: 2009-2018.
34. Kaushansky, N., M. C. Zhong, N. Kerlero de Rosbo, R. Hoeftberger, H. Lassmann, and A. Ben-Nun. 2006. Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL/J mice. J. Immunol. 177: 7364-7376.
35. Pettinelli, C. B., and D. E. McFarlin. 1981. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J. Immunol. 127: 1420-1423.
36. Bernard, P., C. Prost, P. Aucouturier, N. Durepaire, F. Denis, and J. M. Bonnetblanc. 1991. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J. Invest. Dermatol. 97: 259-263.
37. Sitaru, C., S. Mihai, and D. Zillikens. 2007. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch. Dermatol. Res. 299: 1-8.
38. Olivry, T., A. Petersen, S. M. Dunston, and M. Chen. 2000. Novel localised variant of canine epidermolysis bullosa acquisita. Vet. Rec. 146: 193-194.
39. Hill, P. B., P. Boyer, P. Lau, J. Rybnicek, J. Hargreaves, and T. Olivry. 2008. Epidermolysis bullosa acquisita in a Great Dane. J. Small Anim. Pract. 49: 89-94.
40. Olivry, T., L. S. Chan, L. Xu, P. Chace, S. M. Dunston, M. Fahey, and M. P. Marinkovich. 1999. Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2). Vet. Pathol. 36: 328-335.
41. Iwasaki, T., T. Olivry, J. C. Lapiere, L. S. Chan, C. Peavey, Y. Y. Liu, J. C. Jones, P. J. Ihrke, and D. T. Woodley. 1995. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies. Vet. Pathol. 32: 387-393.
42. Olivry, T., M. L. Mirsky, W. Singleton, S. M. Dunston, A. K. Borrillo, L. Xu, T. Traczyk, D. L. Rosolia, and L. S. Chan. 2000. A spontaneously arising porcine model of bullous pemphigoid. Arch. Dermatol. Res. 292: 37-45.
43. Olivry, T., A. K. Borrillo, L. Xu, S. M. Dunston, N. M. Slovis, V. K. Affolter, T. C. Demanuelle, and L. S. Chan. 2000. Equine bullous pemphigoid IgG autoantibodies target linear epitopes in the NC16A ectodomain of collagen XVII (BP180, BPAG2). Vet. Immunol. Immunopathol. 73: 45-52.